申请人:UCB Biopharma SRL
公开号:US20210094941A1
公开(公告)日:2021-04-01
The application relates to a series of 2-imino-6-methylhexahydropyrimidin-4-one derivatives and 3-imino-5-methyl-1,2,4-thiadiazinane 1,1-dioxide derivatives of formula (I), substituted by an arylaminophenyl or heteroarylaminophenyl moiety. The compounds are potent inhibitors of the growth and propagation of the
Plasmodium falciparum
parasite in human blood and thus useful as pharmaceutical agents for the treatment of malaria.